Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives

OBJECTIVES: Molecular assays on nasopharyngeal swabs remain the cornerstone of COVID-19 diagnostics. The high technicalities of nasopharyngeal sampling and molecular assays, as well as scarce resources of reagents, limit our testing capabilities. Several strategies failed, to date, to fully alleviat...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Hingrat, Quentin, Visseaux, Benoit, Laouenan, Cédric, Tubiana, Sarah, Bouadma, Lila, Yazdanpanah, Yazdan, Duval, Xavier, Burdet, Charles, Ichou, Houria, Damond, Florence, Bertine, Mélanie, Benmalek, Nabil, Choquet, Christophe, Timsit, Jean-François, Ghosn, Jade, Charpentier, Charlotte, Descamps, Diane, Houhou-Fidouh, Nadhira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724284/
https://www.ncbi.nlm.nih.gov/pubmed/33307227
http://dx.doi.org/10.1016/j.cmi.2020.11.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724284/
https://www.ncbi.nlm.nih.gov/pubmed/33307227
http://dx.doi.org/10.1016/j.cmi.2020.11.025

Ejemplares similares